A message from the Chair
2018/19 has seen a year of growth and change for CHL. Our proof of concept new commissioning model contracts with Bury Council and with GMMH as lead provider of substance misuse services across Bolton, Salford and Trafford were implemented at the beginning of the financial year with support from both GM and Bolton LPCs. Both contracts were renewed into the next financial year (19-20), demonstrating the commissioners’ satisfaction with CHL in delivery to the SLA, cost and relationship management.
CHL has also worked hard this year to firm up its position in the GM NHS landscape, confirming a seat at all key decision-making forums and boards including Primary Care Provider Board and LPN Steering Group.
GMLPC agreed to invest in CHL’s growth through the funding of a Service Development Lead role for a 12-month fixed term. Alison Scowcroft was appointed and started in November and her impact on CHL as an organisation has been significant. Alison has brought professionalism and respect to the organisation and helped CHL to secure new commissioned services fort GM contractors.
Through Alison’s management of the Bury Find & Treat pilot, North Manchester Hypertension pilot scoping, Inhaler Technique Service and CHL’s existing contracts with Bury Council and GMMH, CHL’s profile and reputation with GMHSCP, and other NHS organisations and commissioners has been undoubtedly raised, embedding its position as the provider company of choice in GM.
A considerable amount of time has also been invested into setting out the infrastructure within CHL, its rules, articles and membership, how it operates as an organisation, process mapping and business planning. This valuable work will continue into the following financial year as CHL sets itself up to deliver the growth which is planned for the next 3-5 years and will ensure complete transparency to members, affiliate members and founding LPCs on all aspects of work undertaken.
You can contact any of the team on email@example.com